Arkolith/Insider Trading/IDRA/Form 4

Wooten Ronald J

DirectorIDERA PHARMACEUTICALS, INC. (IDRA) · full profile →Form 4 · filed Sep 30, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 28, 2022Other(J)5——5

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 28, 2022Other(J)14K——14K
Sep 28, 2022Other(J)1.3M——1.3M
Sep 28, 2022Other(J)14K——14K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-104798) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML